Mountain Valley MD Executes Soluvec™ 1% License Agreement, Expands Patent Protection
May 08, 2023 09:15 ET
|
Mountain Valley MD Holdings Inc.
TORONTO, May 08, 2023 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP) is pleased to announce that Mountain Valley MD Inc....
Mountain Valley MD Holdings Provides Business Update
April 28, 2022 08:55 ET
|
Mountain Valley MD Holdings Inc.
TORONTO, April 28, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF) (FRA: 20MP) is pleased to provide a business update on its...
Mountain Valley MD Holdings Appoints Dr. Elizabeth Norton to Advisory Role to Support Key Quicksome™ Vaccine and Cold Chain Projects
March 16, 2022 09:00 ET
|
Mountain Valley MD Holdings Inc.
TORONTO, March 16, 2022 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF) (FRA: 20MP) is pleased to announce the appointment of Dr. Elizabeth...
Mountain Valley MD Holdings Provides Business Update, Results of Shareholder Meeting
September 29, 2021 16:01 ET
|
Mountain Valley MD Holdings Inc.
TORONTO, Sept. 29, 2021 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQX: MVMDF) (FRA: 20MP) is pleased to provide a business update on key...